Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

被引:122
作者
Bond, M
Murphy, G
Bennett, MR
Newby, AC
Baker, AH
机构
[1] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol BS2 8HW, Avon, England
[2] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[3] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[4] Univ Glasgow, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland
关键词
D O I
10.1074/jbc.M111507200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue inhibitors of metalloproteinases (TIMPs) are important regulators of matrix metalloproteinase (MMP) and adamalysin metalloproteinase activity. We previously reported that overexpression of TIMP-3 inhibits MMPs and induces apoptotic cell death in a variety of cell types and demonstrated that apoptosis is mediated through the N terminus of TIMP-3, which harbors the MMP inhibitory domain. However, little is known about the mechanisms underlying TIMP-3-induced apoptosis. Here we demonstrate that overexpression of TIMP-3 induced activation of initiator caspase-8 and -9 and promoted caspase-mediated cleavage of the death substrates poly(ADP-ribose) polymerase and focal adhesion kinase. Furthermore, TIMP-3 induced mitochondrial activation as demonstrated by loss of mitochondrial membrane potential and release of cytochrome c. Intervention studies demonstrated that overexpression of Bcl-2, the anti-apoptotic mitochondrial membrane protein, or CrmA, a viral serpin inhibitor of caspase-8, completely inhibited TIMP-3-induced apoptosis. Furthermore, a dominant-negative Fas-associated death domain mutant inhibited TIMP-3-induced death substrate cleavage and apoptotic death. Taken together, these results indicate that TIMP-3 overexpression induces a type II apoptotic pathway initiated via a Fas-associated death domain-dependent mechanism.
引用
收藏
页码:13787 / 13795
页数:9
相关论文
共 61 条
  • [1] Life-or-death decisions by the Bcl-2 protein family
    Adams, JM
    Cory, S
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) : 61 - 66
  • [2] Ahonen M, 2000, J INVEST DERMATOL, V115, P575
  • [3] Ahonen M, 1998, CANCER RES, V58, P2310
  • [4] TNF-α converting enzyme (TACE) is inhibited by TIMP-3
    Amour, A
    Slocombe, PM
    Webster, A
    Butler, M
    Knight, CG
    Smith, BJ
    Stephens, PE
    Shelley, C
    Hutton, M
    Knäuper, V
    Docherty, AJP
    Murphy, G
    [J]. FEBS LETTERS, 1998, 435 (01) : 39 - 44
  • [5] A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth
    AnandApte, B
    Bao, L
    Smith, R
    Iwata, K
    Olsen, BR
    Zetter, B
    Apte, SS
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (06): : 853 - 862
  • [6] The Bcl-2 protein family
    Antonsson, B
    Martinou, JC
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 50 - 57
  • [7] CLONING OF THE CDNA-ENCODING HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP-3) AND MAPPING OF THE TIMP3 GENE TO CHROMOSOME-22
    APTE, SS
    MATTEI, MG
    OLSEN, BR
    [J]. GENOMICS, 1994, 19 (01) : 86 - 90
  • [8] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [9] Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
    Baker, AH
    George, SJ
    Zaltsman, AB
    Murphy, G
    Newby, AC
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1347 - 1355
  • [10] Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro - TIMP-3 promotes apoptosis
    Baker, AH
    Zaltsman, AB
    George, SJ
    Newby, AC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) : 1478 - 1487